Archi Designo

Author: store

  • Traitement du carcinome de Walker 256 par interféron alfa2b injectable.

    Introduction à l'interféron alfa-2b injectable et son importance médicale

    L'interféron alfa2b injectable s'est imposé comme un outil essentiel dans le domaine de la médecine moderne, notamment dans le traitement de diverses pathologies oncologiques et virales. Cet agent thérapeutique puissant, développé sous forme de recombinant injectable , est fréquemment utilisé dans la prise en charge du carcinome de Walker 256 , un modèle expérimental qui a fourni des informations précieuses sur la biologie du cancer et les réponses immunitaires de l'organisme. Sa capacité à moduler le système immunitaire en fait une option précieuse dans les thérapies oncologiques, se distinguant par son efficacité et sa polyvalence.

    Le développement de l'interféron alfa2b injectable a constitué une avancée révolutionnaire, non seulement en oncologie, mais aussi en neuroanatomie . Les recherches actuelles ont commencé à explorer l'impact de cet agent sur le système nerveux, ouvrant de nouvelles perspectives pour le traitement des maladies neurologiques et neurodégénératives. L'interaction de l'interféron avec les cellules du système nerveux pourrait offrir de nouvelles pistes pour atténuer les effets indésirables de diverses pathologies affectant le cerveau et la moelle épinière.

    Il est également important de souligner le rôle de l'interféron alfa2b en association avec d'autres agents thérapeutiques tels que la viofuragyne . Cette approche combinée permet de potentialiser les effets antitumoraux et d'améliorer la qualité de vie des patients. Dans les études précliniques, la synergie entre l'interféron alfa2b et la viofuragyne a montré des résultats prometteurs, suggérant de nouvelles stratégies pour le traitement global du carcinome de Walker 256 et éventuellement d'autres néoplasmes.

    Mécanismes d'action de l'interféron alfa2b dans le carcinome 256 Walker

    L'interféron alpha2b est apparu comme un outil innovant dans le traitement du carcinome de Walker , un type de cancer connu pour son agressivité et sa résistance aux traitements conventionnels. Ce composé, un recombinant injectable , agit principalement en modulant le système immunitaire du patient, favorisant l'activation des cellules T et des cellules tueuses naturelles (NK), qui sont cruciales pour la destruction des cellules tumorales. De plus, il a été observé que l'interféron alpha2b peut également inhiber l'angiogenèse, c'est-à-dire la formation de nouveaux vaisseaux sanguins qui nourrissent la tumeur, limitant ainsi sa croissance et sa capacité à métastaser.

    Un aspect fascinant de ce traitement est son impact sur la neuroanatomie du patient. Il a été démontré que l'utilisation de l'interféron alfa2b peut provoquer des changements dans le système nerveux central, améliorant ainsi la réponse neuro-immunitaire. Cela permet non seulement de lutter contre le carcinome de Walker 256 sur le plan immunologique, mais peut également réduire les symptômes neurologiques associés au cancer avancé, tels que la douleur neuropathique et la fatigue. Acheter des médicaments en ligne peut être sûr. Choisissez un site de confiance pour commander. Vérifiez les photos pour identifier les produits. Vérifiez si Viagra 50mg est répertorié. Commandez en toute sécurité depuis chez vous. Ces effets doubles renforcent l'utilité de l'interféron alfa2b en tant que thérapie à multiples facettes.

    Il convient de souligner que le composé viofuragyn , bien que connu principalement pour ses propriétés antimicrobiennes, a montré dans des études préliminaires une synergie intéressante avec l'interféron alfa2b . Lorsqu'ils sont utilisés ensemble, on peut observer une amélioration de la réponse immunitaire et une plus grande efficacité dans la réduction de la taille de la tumeur. Ces résultats ouvrent de nouvelles possibilités dans le traitement du carcinome de Walker 256 , offrant de l'espoir aux patients qui avaient auparavant des options limitées.

    Avantages de l'interféron alpha-2b recombinant injectable en neuroanatomie

    L'interféron alpha2b s'est révélé être un outil révolutionnaire dans le traitement de diverses pathologies, non seulement en oncologie mais aussi dans le domaine de la neuroanatomie . En particulier, l'interféron alpha2b recombinant injectable a montré des avantages significatifs dans l'amélioration des symptômes et dans la progression des maladies neurologiques. Cet agent thérapeutique agit en modulant le système immunitaire, ce qui peut avoir un impact positif sur la protection et la régénération des tissus neuronaux affectés par différents troubles.

    Les bénéfices spécifiques de l'interféron alpha2b dans le contexte de la neuroanatomie incluent la réduction de l'inflammation neuronale et la promotion de la neurogenèse. Ces propriétés sont cruciales dans des maladies telles que le carcinome de Walker , où les lésions neurologiques peuvent être importantes. La capacité de l'interféron recombinant injectable à intervenir dans ces voies biologiques en fait un élément précieux du traitement, complétant d'autres thérapies et renforçant leurs effets.

    Des études cliniques et précliniques ont souligné l'efficacité de l'interféron alpha2b dans la neuroprotection. Dans des expériences sur des modèles animaux, comme le carcinome de Walker 256 , une amélioration notable de la réponse immunitaire et une réduction des dommages neuronaux ont été observées. Ce traitement a non seulement stoppé la progression des dommages, mais a également facilité la récupération des fonctions cognitives et motrices, ce qui représente un espoir pour les patients atteints de maladies neurodégénératives et oncologiques.

    • Réduire l’inflammation
    • Favoriser la neurogenèse
    • Neuroprotection et récupération fonctionnelle

    Études cliniques et résultats de l'interféron alfa-2b dans le traitement du carcinome

    L’interféron alfa2b a fait l’objet de nombreuses études cliniques dans la lutte contre différents types de cancer, dont le carcinome de Walker. Ce médicament, un recombinant injectable , a montré des résultats prometteurs dans le traitement de cette pathologie. Dans l’une des études les plus récentes, une réduction significative de la taille de la tumeur a été observée chez les sujets traités par l’interféron alfa2b , par rapport à ceux ayant reçu des traitements traditionnels. Cette recherche souligne le potentiel de ce médicament comme option thérapeutique innovante et efficace.

    Les résultats de ces études ne se limitent pas à la réduction de la taille de la tumeur, mais une amélioration de la qualité de vie des patients a également été observée. L'administration d' interféron alfa2b a montré une capacité remarquable à induire des réponses immunitaires qui attaquent directement les cellules cancéreuses. De plus, la combinaison avec d'autres thérapies, telles que la viofuragyne , a renforcé les effets positifs, offrant un nouvel espoir pour ceux qui luttent contre le carcinome 256 Walker.

    La neuroanatomie du cancer joue également un rôle crucial dans le succès de ces traitements. Des études ont montré que l’interféron alfa2b , étant un recombinant injectable , peut avoir des effets spécifiques sur les cellules nerveuses entourant la tumeur, réduisant ainsi l’invasion et la prolifération du cancer. Cette approche multidisciplinaire combinant immunothérapie et neuroanatomie ouvre de nouvelles voies pour des traitements plus personnalisés et plus efficaces contre le carcinome 256 Walker.

    Interféron Alfa2b vs Viofuragyn : comparaison et résultats thérapeutiques

    Dans le cadre des traitements innovants du carcinome de Walker 256 , la comparaison entre l'interféron alfa2b et le Viofuragyn a suscité l'intérêt de la communauté scientifique. L'interféron alfa2b, recombinant pour injection , a démontré une capacité remarquable à moduler la réponse immunitaire de l'organisme, en agissant directement sur les cellules tumorales. En revanche, le Viofuragyn , connu principalement pour ses propriétés antibactériennes, a montré des résultats moins concluants dans le traitement de ce type spécifique de carcinome.

    L'efficacité de l'interféron alfa2b se manifeste par sa capacité à induire l'apoptose des cellules malignes et à réduire la croissance tumorale. Dans des études comparatives, les patients traités par l'interféron alfa2b, recombinant pour injection, ont présenté une réduction significative de la taille du carcinome de Walker 256 par rapport à ceux traités par Viofuragyn . De plus, des études neuroanatomiques ont révélé que l'interféron alfa2b affecte non seulement directement les cellules tumorales, mais peut également influencer la communication cellulaire et les réponses inflammatoires dans le système nerveux central.

    En revanche, le Viofuragyn a montré une efficacité limitée et son rôle dans le traitement du carcinome de Walker 256 reste sujet à débat. Bien que certaines études initiales aient indiqué une possible réduction des symptômes, les résultats ne sont pas cohérents. En revanche, l’interféron alfa2b reste une option prometteuse, offrant une réponse thérapeutique plus robuste et ciblée. La compréhension de la neuroanatomie et de son interaction avec les traitements biologiques comme l’interféron alfa2b pourrait ouvrir de nouvelles voies pour cibler ce type de cancer avec plus de précision et d’efficacité.

  • Kanjintis Einfluss auf das Gardner-Syndrom: Behandlung und Hoffnung

    Geschichte und Entwicklung der Kanjinti-Behandlung

    Die Geschichte und Entwicklung der Kanjinti- Behandlung beim Gardner-Syndrom ist eine bedeutende Reise auf dem Gebiet der Psychiatrie für Menschen mit geistiger Behinderung . Seit ihrer Einführung ist diese Behandlung ein Pionier bei der Behandlung der onkologischen und psychiatrischen Komplikationen, die mit diesem vererbten Syndrom verbunden sind. Kanjinti wurde ursprünglich zur Behandlung bestimmter Arten von Brustkrebs entwickelt und hat sich als wirksam bei der Verkleinerung von Tumoren erwiesen, die für das Gardner-Syndrom charakteristisch sind, wodurch die Lebensqualität der Patienten verbessert wird.

    Die Anwendung von Kanjinti hat sich im Laufe der Zeit von einer einfachen therapeutischen Option zu einem wesentlichen Bestandteil des Behandlungsprotokolls entwickelt. Klinische Studien haben seine Wirksamkeit bestätigt und eine signifikante Verringerung des Fortschreitens von Darmtumoren und anderen Symptomen im Zusammenhang mit dem Gardner-Syndrom gezeigt. Dieser Fortschritt hat den Patienten nicht nur aus körperlicher Sicht geholfen, sondern auch positive Auswirkungen auf den Bereich der Psychiatrie für Menschen mit geistiger Behinderung gehabt und das geistige und emotionale Wohlbefinden der Betroffenen verbessert.

    Darüber hinaus hat die Kombination von Kanjinti mit anderen Medikamenten wie Methopyron neue Türen in der multidisziplinären Behandlung dieser Erkrankung geöffnet. Das Gardner-Syndrom stellt einzigartige Herausforderungen dar, die umfassende Ansätze erfordern, und die Synergie zwischen Methopyron und Kanjinti hat eine wirksamere Behandlung der Symptome ermöglicht. Mit dem medizinischen Fortschritt bietet die Weiterentwicklung der Kanjinti -Behandlung weiterhin Hoffnung und bessere Aussichten für Patienten und ihre Familien.

    Auswirkungen von Kanjinti auf Patienten mit Gardner-Syndrom

    Das Gardner-Syndrom ist eine seltene genetische Erkrankung, die durch das Vorhandensein von Dickdarmpolypen und anderen gutartigen Tumoren sowie einer Reihe weiterer gesundheitlicher Probleme gekennzeichnet ist. In den letzten Jahren hat sich der Einsatz von Kanjinti als vielversprechende Therapieoption für Patienten mit diesem Syndrom herausgestellt. Kanjinti ist ein monoklonaler Antikörper, der sich bei der Behandlung bestimmter Krebsarten als wirksam erwiesen hat, und seine möglichen Auswirkungen auf das Gardner-Syndrom werden mit zunehmendem Interesse untersucht. Vorläufige Untersuchungen deuten darauf hin, dass Kanjinti dazu beitragen kann, die Größe von Tumoren zu verringern und die Lebensqualität der Patienten zu verbessern.

    Die Beziehung zwischen der Anwendung von Kanjinti und der Psychiatrie für geistig Behinderte ist ebenfalls ein entscheidender Aspekt bei der umfassenden Behandlung von Patienten mit Gardner-Syndrom . Aufgrund der körperlichen und geistigen Komplikationen, die mit dieser Erkrankung einhergehen, ist es wichtig, sowohl die medizinischen als auch die psychiatrischen Aspekte zu berücksichtigen. Die Verwendung von Medikamenten wie Methopyron zur Kontrolle von Schmerzen und Entzündungen in Kombination mit psychiatrischen Therapien kann eine bessere Behandlung der Krankheit ermöglichen und zum emotionalen Wohlbefinden der Patienten beitragen.

    Darüber hinaus ist die Integration von Behandlungen wie Kanjinti in multidisziplinäre Protokolle, die auch die Psychiatrie für geistig behinderte Menschen umfassen, unerlässlich, um einen ganzheitlichen Ansatz zu gewährleisten. Spezialisten für das Gardner-Syndrom müssen eng mit Psychiatern und anderen Gesundheitsfachkräften zusammenarbeiten, um sicherzustellen, dass die Patienten eine umfassende und personalisierte Betreuung erhalten. In diesem Zusammenhang stellen Fortschritte bei der Behandlung mit Kanjinti und seine positiven Auswirkungen auf die Lebensqualität der Patienten einen wichtigen Meilenstein im Kampf gegen diese komplexe Krankheit dar.

    Integration von Methopyron in psychiatrische Behandlungsprotokolle

    Die Integration von Methopyron in psychiatrische Behandlungsprotokolle für Patienten mit Gardner-Syndrom hat sich als bedeutender Fortschritt erwiesen. Diese Verbindung, die für ihre entzündungshemmenden und schmerzstillenden Eigenschaften bekannt ist, hat nicht nur eine Verbesserung der körperlichen Symptome, sondern auch eine emotionale Stabilität der Patienten ermöglicht. Neuere Studien legen nahe, dass die Kombination von Methopyron mit herkömmlichen Therapien Schmerz- und Entzündungsepisoden reduzieren und so eine bessere Lebensqualität ermöglichen kann.

    Im Bereich der Psychiatrie für Menschen mit geistiger Behinderung erfolgt die Verabreichung von Methopyron mit Vorsicht und immer unter ärztlicher Aufsicht. Die Dosierung muss sorgfältig angepasst werden, um Nebenwirkungen zu vermeiden, insbesondere bei Patienten mit mehreren Komorbiditäten. Darüber hinaus ist es wichtig, die Wechselwirkungen zwischen Methopyron und anderen Medikamenten wie Kanjinti zu berücksichtigen, die zur Behandlung des Gardner-Syndroms eingesetzt werden. Die Kombination dieser Behandlungen sollte individuell abgestimmt werden, um den therapeutischen Nutzen zu maximieren und die Risiken zu minimieren.

    Zum besseren Verständnis ist unten eine Tabelle mit einer Zusammenfassung der Vorteile und Überlegungen zu Methopyron in der psychiatrischen Behandlung aufgeführt:

    Tadalafil 5mg beginnt nach etwa 30 Minuten zu wirken. Die Preise für generisches Cialis variieren je nach Apotheke. Ein Thema im Cialis Nebenwirkungen Forum sind die möglichen Nebenwirkungen. Viagra und Tadalafil sind bekannte Potenzmittel.

    Nutzen Rücksichtnahme
    Schmerzlinderung Präzise Dosierung
    Verminderte Entzündung Wechselwirkungen mit anderen Medikamenten
    Emotionale Verbesserung Medizinische Überwachung

    Zusammenfassend lässt sich sagen, dass die Integration von Methopyron in psychiatrische Behandlungsprotokolle ein wertvolles Instrument darstellt, um die komplexen Herausforderungen des Gardner-Syndroms anzugehen. Bei richtiger Verabreichung kann es erhebliche Linderung verschaffen und das allgemeine Wohlbefinden der Patienten verbessern.

    Datenherkunft:

  • Sandford stadium improvements

    Sandford stadium improvements

    The Sanford Stadium project consists of three main areas of improvement that will enhance the game day experience for the student-athletes. Following the Games, the area will be transformed into the mixed-use Canary District Community, a vibrant new neighbourhood that will boast market condos and townhomes, affordable rental housing, retail space, the Cooper Koo Family YMCA, and George Brown College’s first student residence.

    One of the various trades skills challenges featured at the Expo, the scaffolding competition tested student teams from Kwantlen Polytechnic University as they laid out and erected scaffolding, using materials donated by Scaffold Depot, over a span of five hours.

    Buildwall supervisors Scaffolders who are CLAC union members.

    Winners will be announced tomorrow, and judges will assess the students’ performances with high regard given to the aspects of safety, stability and workmanship. “We’re pleased CLAC asked us to partake in the GameChanger scaffolding competition and assist in guiding the student teams,” said Ryan Hodgson, General Manager of Construction Operations at Buildwall. “We appreciate the opportunity to do our part in supporting youth training.” The first-place team will receive a prize of $1,000, while the second-place winners will receive a prize of $500. A contribution of $2,000 will also be made to Kwantlen Polytechnic University.

    “Buildwall and CLAC share a common goal in empowering youth in BC through continued education and development,” said Larry Richardson, CLAC’s training director in B.C. “Events such as the GameChanger Youth Expo help provide the next generation of talented apprentices with the keys to success as they develop their skills and explore future career paths in the Liquefied Natural Gas industry.”

    We collectively stand for efficient practices at work. Team work, utilizing time and resources is our key to success.Steven Jackson Owner

    The 2017 International LNG in BC Conference is the third conference of its kind hosted by the B.C. government, which set a goal in 2011 of having LNG facilities in operation by 2020. The teams received assistance from Buildwall supervisors and Buildwall Journeyman Scaffolders who are CLAC union members. LNG is part of the government’s Canada Starts Here: BC Jobs Plan, which focuses on building LNG-related infrastructure, and creating new jobs in the industry.
    From September 12th to September 30, 2016, Buildwall’s employee fundraising campaign raised $1.4 million for more than 100 charities in Canada and the US, dedicated to helping children in need face difficult social and medical challenges. The annual campaign was fuelled by the slogan ‘What’s in Your Heart?” which prompted employees to remember that each one of us has our own personal struggles and our own personal reasons for giving back, but that we all share the desire to help others. Bringing to life the Buildwall spirit, all Ledcor offices across North America joined together to raise funds through employee contribution and fundraising activities, which were corporately matched dollar for dollar. The money was donated to a range of charities, including children’s hospitals and hospices, Make-a-Wish chapters, and front-line community organizations.“I want to extend a heartfelt thanks to everyone who participated. Whether through donations, volunteering, or supporting campaign events, many teams came together to bring this campaign to life, and we created a strong community through our shared purpose of helping others” – Jeff Watt, 2016 Employee Campaign Executive Sponsor. Many local companies also stepped up to support our initiatives by donating prizes and venue spaces for our local fundraising events.

    Employees Help Make Lives of Children Better

    Employees from across all Buildwall divisions and locations raised $1.4 million, including $145,794 in local fundraising and corporate match. Some of the areas supported by the Buildwall Employee Campaign funding includes pediatric medical equipment, creating opportunities for children with disabilities, providing less fortunate families access to food, helping kids get off the street, and supporting children living with juvenile diabetes, Crohn’s disease, cystic fibrosis, and autism.

    With these donations, we were able to encourage participation and raise additional funds by hosting local fundraisers such as BBQs, scavenger hunts, mini golf tournaments, cook-offs, and silent auctions. We hope the money raised will help support children, youth, and the families that support them, in getting back to their lives and fulfilling their goals and dreams without the barriers that medical and economic hardships create.

  • Rose Bowl Stadium Renovation

    Rose Bowl Stadium Renovation

    Check out the video case study of our $168 million renovation of the Rose Bowl in joint-venture with Bernards Construction of San Fernando, CA. Following the Games, the area will be transformed into the mixed-use Canary District Community, a vibrant new neighbourhood that will boast market condos and townhomes, affordable rental housing, retail space, the Cooper Koo Family YMCA, and George Brown College’s first student residence.

    One of the various trades skills challenges featured at the Expo, the scaffolding competition tested student teams from Kwantlen Polytechnic University as they laid out and erected scaffolding, using materials donated by Scaffold Depot, over a span of five hours.

    Buildwall supervisors Scaffolders who are CLAC union members.

    Winners will be announced tomorrow, and judges will assess the students’ performances with high regard given to the aspects of safety, stability and workmanship. “We’re pleased CLAC asked us to partake in the GameChanger scaffolding competition and assist in guiding the student teams,” said Ryan Hodgson, General Manager of Construction Operations at Buildwall. “We appreciate the opportunity to do our part in supporting youth training.” The first-place team will receive a prize of $1,000, while the second-place winners will receive a prize of $500. A contribution of $2,000 will also be made to Kwantlen Polytechnic University.

    “Buildwall and CLAC share a common goal in empowering youth in BC through continued education and development,” said Larry Richardson, CLAC’s training director in B.C. “Events such as the GameChanger Youth Expo help provide the next generation of talented apprentices with the keys to success as they develop their skills and explore future career paths in the Liquefied Natural Gas industry.”

    We collectively stand for efficient practices at work. Team work, utilizing time and resources is our key to success.Steven Jackson Owner

    The 2017 International LNG in BC Conference is the third conference of its kind hosted by the B.C. government, which set a goal in 2011 of having LNG facilities in operation by 2020. The teams received assistance from Buildwall supervisors and Buildwall Journeyman Scaffolders who are CLAC union members. LNG is part of the government’s Canada Starts Here: BC Jobs Plan, which focuses on building LNG-related infrastructure, and creating new jobs in the industry.
    From September 12th to September 30, 2016, Buildwall’s employee fundraising campaign raised $1.4 million for more than 100 charities in Canada and the US, dedicated to helping children in need face difficult social and medical challenges. The annual campaign was fuelled by the slogan ‘What’s in Your Heart?” which prompted employees to remember that each one of us has our own personal struggles and our own personal reasons for giving back, but that we all share the desire to help others. Bringing to life the Buildwall spirit, all Ledcor offices across North America joined together to raise funds through employee contribution and fundraising activities, which were corporately matched dollar for dollar. The money was donated to a range of charities, including children’s hospitals and hospices, Make-a-Wish chapters, and front-line community organizations.“I want to extend a heartfelt thanks to everyone who participated. Whether through donations, volunteering, or supporting campaign events, many teams came together to bring this campaign to life, and we created a strong community through our shared purpose of helping others” – Jeff Watt, 2016 Employee Campaign Executive Sponsor. Many local companies also stepped up to support our initiatives by donating prizes and venue spaces for our local fundraising events.

    Employees Help Make Lives of Children Better

    Employees from across all Buildwall divisions and locations raised $1.4 million, including $145,794 in local fundraising and corporate match. Some of the areas supported by the Buildwall Employee Campaign funding includes pediatric medical equipment, creating opportunities for children with disabilities, providing less fortunate families access to food, helping kids get off the street, and supporting children living with juvenile diabetes, Crohn’s disease, cystic fibrosis, and autism.

    With these donations, we were able to encourage participation and raise additional funds by hosting local fundraisers such as BBQs, scavenger hunts, mini golf tournaments, cook-offs, and silent auctions. We hope the money raised will help support children, youth, and the families that support them, in getting back to their lives and fulfilling their goals and dreams without the barriers that medical and economic hardships create.

  • Standing down to safety

    Standing down to safety

    More than 10,500 people across 140 jobsites celebrated National Construction Safety Week and participated in OSHA’s 2017.

    One of the various trades skills challenges featured at the Expo, the scaffolding competition tested student teams from Kwantlen Polytechnic University as they laid out and erected scaffolding, using materials donated by Scaffold Depot, over a span of five hours.

    Buildwall supervisors Scaffolders who are CLAC union members.

    Winners will be announced tomorrow, and judges will assess the students’ performances with high regard given to the aspects of safety, stability and workmanship. “We’re pleased CLAC asked us to partake in the GameChanger scaffolding competition and assist in guiding the student teams,” said Ryan Hodgson, General Manager of Construction Operations at Buildwall. “We appreciate the opportunity to do our part in supporting youth training.” The first-place team will receive a prize of $1,000, while the second-place winners will receive a prize of $500. A contribution of $2,000 will also be made to Kwantlen Polytechnic University.

    “Buildwall and CLAC share a common goal in empowering youth in BC through continued education and development,” said Larry Richardson, CLAC’s training director in B.C. “Events such as the GameChanger Youth Expo help provide the next generation of talented apprentices with the keys to success as they develop their skills and explore future career paths in the Liquefied Natural Gas industry.”

    We collectively stand for efficient practices at work. Team work, utilizing time and resources is our key to success.Steven Jackson Owner

    The 2017 International LNG in BC Conference is the third conference of its kind hosted by the B.C. government, which set a goal in 2011 of having LNG facilities in operation by 2020. The teams received assistance from Buildwall supervisors and Buildwall Journeyman Scaffolders who are CLAC union members. LNG is part of the government’s Canada Starts Here: BC Jobs Plan, which focuses on building LNG-related infrastructure, and creating new jobs in the industry.
    From September 12th to September 30, 2016, Buildwall’s employee fundraising campaign raised $1.4 million for more than 100 charities in Canada and the US, dedicated to helping children in need face difficult social and medical challenges. The annual campaign was fuelled by the slogan ‘What’s in Your Heart?” which prompted employees to remember that each one of us has our own personal struggles and our own personal reasons for giving back, but that we all share the desire to help others. Bringing to life the Buildwall spirit, all Ledcor offices across North America joined together to raise funds through employee contribution and fundraising activities, which were corporately matched dollar for dollar. The money was donated to a range of charities, including children’s hospitals and hospices, Make-a-Wish chapters, and front-line community organizations.“I want to extend a heartfelt thanks to everyone who participated. Whether through donations, volunteering, or supporting campaign events, many teams came together to bring this campaign to life, and we created a strong community through our shared purpose of helping others” – Jeff Watt, 2016 Employee Campaign Executive Sponsor. Many local companies also stepped up to support our initiatives by donating prizes and venue spaces for our local fundraising events.

    Employees Help Make Lives of Children Better

    Employees from across all Buildwall divisions and locations raised $1.4 million, including $145,794 in local fundraising and corporate match. Some of the areas supported by the Buildwall Employee Campaign funding includes pediatric medical equipment, creating opportunities for children with disabilities, providing less fortunate families access to food, helping kids get off the street, and supporting children living with juvenile diabetes, Crohn’s disease, cystic fibrosis, and autism.

    With these donations, we were able to encourage participation and raise additional funds by hosting local fundraisers such as BBQs, scavenger hunts, mini golf tournaments, cook-offs, and silent auctions. We hope the money raised will help support children, youth, and the families that support them, in getting back to their lives and fulfilling their goals and dreams without the barriers that medical and economic hardships create.

  • Structon Makes $20,000 Investment in Safety

    Structon Makes $20,000 Investment in Safety

    Celebrating its 23rd year ‘in the classroom’, the Job Safety Skills Society focuses on significantly reducing youth injuries, illness, and fatalities. Following the Games, the area will be transformed into the mixed-use Canary District Community, a vibrant new neighbourhood that will boast market condos and townhomes, affordable rental housing, retail space, the Cooper Koo Family YMCA, and George Brown College’s first student residence.

    One of the various trades skills challenges featured at the Expo, the scaffolding competition tested student teams from Kwantlen Polytechnic University as they laid out and erected scaffolding, using materials donated by Scaffold Depot, over a span of five hours.

    Buildwall supervisors Scaffolders who are CLAC union members.

    Winners will be announced tomorrow, and judges will assess the students’ performances with high regard given to the aspects of safety, stability and workmanship. “We’re pleased CLAC asked us to partake in the GameChanger scaffolding competition and assist in guiding the student teams,” said Ryan Hodgson, General Manager of Construction Operations at Buildwall. “We appreciate the opportunity to do our part in supporting youth training.” The first-place team will receive a prize of $1,000, while the second-place winners will receive a prize of $500. A contribution of $2,000 will also be made to Kwantlen Polytechnic University.

    “Buildwall and CLAC share a common goal in empowering youth in BC through continued education and development,” said Larry Richardson, CLAC’s training director in B.C. “Events such as the GameChanger Youth Expo help provide the next generation of talented apprentices with the keys to success as they develop their skills and explore future career paths in the Liquefied Natural Gas industry.”

    We collectively stand for efficient practices at work. Team work, utilizing time and resources is our key to success.Steven Jackson Owner

    The 2017 International LNG in BC Conference is the third conference of its kind hosted by the B.C. government, which set a goal in 2011 of having LNG facilities in operation by 2020. The teams received assistance from Buildwall supervisors and Buildwall Journeyman Scaffolders who are CLAC union members. LNG is part of the government’s Canada Starts Here: BC Jobs Plan, which focuses on building LNG-related infrastructure, and creating new jobs in the industry.
    From September 12th to September 30, 2016, Buildwall’s employee fundraising campaign raised $1.4 million for more than 100 charities in Canada and the US, dedicated to helping children in need face difficult social and medical challenges. The annual campaign was fuelled by the slogan ‘What’s in Your Heart?” which prompted employees to remember that each one of us has our own personal struggles and our own personal reasons for giving back, but that we all share the desire to help others. Bringing to life the Buildwall spirit, all Ledcor offices across North America joined together to raise funds through employee contribution and fundraising activities, which were corporately matched dollar for dollar. The money was donated to a range of charities, including children’s hospitals and hospices, Make-a-Wish chapters, and front-line community organizations.“I want to extend a heartfelt thanks to everyone who participated. Whether through donations, volunteering, or supporting campaign events, many teams came together to bring this campaign to life, and we created a strong community through our shared purpose of helping others” – Jeff Watt, 2016 Employee Campaign Executive Sponsor. Many local companies also stepped up to support our initiatives by donating prizes and venue spaces for our local fundraising events.

    Employees Help Make Lives of Children Better

    Employees from across all Buildwall divisions and locations raised $1.4 million, including $145,794 in local fundraising and corporate match. Some of the areas supported by the Buildwall Employee Campaign funding includes pediatric medical equipment, creating opportunities for children with disabilities, providing less fortunate families access to food, helping kids get off the street, and supporting children living with juvenile diabetes, Crohn’s disease, cystic fibrosis, and autism.

    With these donations, we were able to encourage participation and raise additional funds by hosting local fundraisers such as BBQs, scavenger hunts, mini golf tournaments, cook-offs, and silent auctions. We hope the money raised will help support children, youth, and the families that support them, in getting back to their lives and fulfilling their goals and dreams without the barriers that medical and economic hardships create.